Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0086418,
umls-concept:C0086597,
umls-concept:C0599944,
umls-concept:C1157567,
umls-concept:C1336606,
umls-concept:C1412824,
umls-concept:C1414467,
umls-concept:C1514562,
umls-concept:C1515655,
umls-concept:C1704675,
umls-concept:C1707271,
umls-concept:C1880389,
umls-concept:C1883204,
umls-concept:C1883221
|
pubmed:issue |
1
|
pubmed:dateCreated |
1999-2-22
|
pubmed:abstractText |
At the termination step of protein synthesis, hydrolysis of the peptidyl-tRNA is jointly catalysed at the ribosome by the termination codon and the polypeptide release factor (eRF1 in eukaryotes). eRF1 forms in vivo and in vitro a stable complex with release factor eRF3, an eRF1-dependent and ribosome-dependent GTPase. The role of the eRF1-eRF3 complex in translation remains unclear. We have undertaken a systematic analysis of the interactions between the human eRF1 and eRF3 employing a yeast two-hybrid assay. We show that the N-terminal parts of eRF1 (positions 1-280) and of eRF3 (positions 1477) are either not involved or non-essential for binding. Two regions in each factor are critical for mutual binding: positions 478-530 and 628-637 of eRF3 and positions 281-305 and 411-415 of eRF1. The GTP binding domain of eRF3 is not involved in complex formation with eRF1. The GILRY pentamer (positions 411-415) conserved in eukaryotes and archaebacteria is critical for eRF1's ability to stimulate eRF3 GTPase. The human eRF1 lacking 22 C-terminal amino acids remains active as a release factor and promotes an eRF3 GTPase activity whereas C-terminally truncated eRF3 is inactive as a GTPase.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ETF1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/GTP Phosphohydrolases,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Termination Factors,
http://linkedlifedata.com/resource/pubmed/chemical/peptide-chain-release factor 3
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0014-5793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
22
|
pubmed:volume |
443
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
41-7
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:9928949-Amino Acid Sequence,
pubmed-meshheading:9928949-Binding Sites,
pubmed-meshheading:9928949-GTP Phosphohydrolases,
pubmed-meshheading:9928949-Humans,
pubmed-meshheading:9928949-Molecular Sequence Data,
pubmed-meshheading:9928949-Mutation,
pubmed-meshheading:9928949-Peptide Chain Termination, Translational,
pubmed-meshheading:9928949-Peptide Fragments,
pubmed-meshheading:9928949-Peptide Termination Factors,
pubmed-meshheading:9928949-Protein Binding,
pubmed-meshheading:9928949-Saccharomyces cerevisiae,
pubmed-meshheading:9928949-Sequence Homology, Amino Acid,
pubmed-meshheading:9928949-Species Specificity
|
pubmed:year |
1999
|
pubmed:articleTitle |
C-terminal domains of human translation termination factors eRF1 and eRF3 mediate their in vivo interaction.
|
pubmed:affiliation |
INSERM U248, Institut Curie, Paris, France.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|